BURLINGTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 3 at 11:20am EST.
A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com
Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com
Media:
Kate Coyle
ICR Inc., 203-682-8210
kate.coyle@icrinc.com
Federal Government Approves Loan Program up to $80,000 for Home Garden Suite for HomeownersToronto, Ontario--(Newsfile…
Leader in liquid biopsy, cancer screening, and monitoring speaks at largest healthcare investment symposium BALTIMORE…
In Motion has been a prominent leader of physical therapy services in the Downingtown community for…
PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- Qualified Health today announced its launch with…
SAN FRANCISCO, Jan. 8, 2025 /PRNewswire/ -- TryStrata, Inc. (Strata), a technology company for doctors,…
Investment in the low triple-digit million Euro rangeSignificant capacity increase with multiple new production linesCustomized…